• About Lareb
    About Lareb
  • Search information about ADRs
    Search information about ADRs
  • Subscribe to newsletter
    Subscribe to newsletter

Updates RSS icon

  • Dimethyl fumarate and alopecia
    The Netherlands Pharmacovigilance Centre Lareb has received 92 cases about alopecia associated with the use of dimethyl fumarate. Alopecia is not described in the Dutch Summary of ...
    Read more
    09 OCT
  • Anastrozole and depressed mood
    The Netherlands Pharmacovigilance Centre Lareb received 14 reports of depressed mood associated with the use of anastrozole (Arimedex®). In the Summary of Product Characteristics o ...
    Read more
    18 SEP
  • Patient organizations can help enable effective communication of adverse drug reactions
    To improve therapeutic decision making, it is crucial that information regarding adverse drug reactions reaches patients. One possible avenue is to collaborate with patient organiz ...
    Read more
    28 JUL
  • Preparation started to monitor the safety and efficacy COVID-19 vaccines
    An European project has been started to prepare for the monitoring of the safety and efficacy of COVID-19 vaccines. This project aims to conduct preparatory research into data sour ...
    Read more
    13 JUL
  • Burden of adverse drugs reactions with biologics
    Infections and musculoskeletal complaints are adverse drug reactions (ADRs) with the highest burden for the patient, while injection site reactions have the lowest burden according ...
    Read more
    05 JUN
  • Flucloxacillin and oesophageal complaints
    The Netherlands Pharmacovigilance Centre Lareb received 22 reports of oesophageal complaints associated with the use of flucloxacillin. The complaints varied from oesophageal pain, ...
    Read more
    27 MAR